| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Antibody targeted therapy in cancer: comparison of murine and clinical studies
|
Begent, R.H.J.
|
|
1990
|
17 |
2-3 |
p. 373-378
6 p.
|
artikel
|
| 2 |
Antiemetic action of 5-HT3 receptor antagonists: review of preclinical and clinical results with ICS 205–930
|
Gamse, R.
|
|
1990
|
17 |
2-3 |
p. 301-305
5 p.
|
artikel
|
| 3 |
Antiemetic control: 5-HT3 antagonists: Review of clinical results, with particular emphasis on ondansetron
|
Kidgell, A.E.
|
|
1990
|
17 |
2-3 |
p. 311-317
7 p.
|
artikel
|
| 4 |
A prospective randomized trial of ICRF-187 for prevention of cumulative doxorubicin-induced cardiac toxicity in women with breast cancer
|
Speyer, J.L.
|
|
1990
|
17 |
2-3 |
p. 161-163
3 p.
|
artikel
|
| 5 |
Batanopride (BMY-25801): A new 5-HT3 receptor antagonist for the prevention of cancer chemotherapy-induced emesis
|
Smaldone, L.
|
|
1990
|
17 |
2-3 |
p. 319-327
9 p.
|
artikel
|
| 6 |
Cisplatin-linked phosphonates in the treatment of the transplantable osteosarcoma in vitro and in vivo
|
Klenner, T.
|
|
1990
|
17 |
2-3 |
p. 253-259
7 p.
|
artikel
|
| 7 |
Combination chemotherapy in radically operated advanced ovarian cancer
|
Petru, E.
|
|
1990
|
17 |
2-3 |
p. 329-334
6 p.
|
artikel
|
| 8 |
Examination of the potential long-lasting protective effect of ICRF-187 against anthracycline-induced chronic cardiomyopathy
|
Herman, Eugene H.
|
|
1990
|
17 |
2-3 |
p. 155-160
6 p.
|
artikel
|
| 9 |
Foreword
|
Berger, Martin R.
|
|
1990
|
17 |
2-3 |
p. 107-
1 p.
|
artikel
|
| 10 |
Glutathione and detoxification
|
Tedeschi, Michele
|
|
1990
|
17 |
2-3 |
p. 203-208
6 p.
|
artikel
|
| 11 |
Gonadal toxicity following cancer therapy in adults: significance, diagnosis, prevention and treatment
|
Kreuser, Ernst-Dietrich
|
|
1990
|
17 |
2-3 |
p. 169-175
7 p.
|
artikel
|
| 12 |
Granisetron (BRL 43694) in the treatment of cytostatic drug-induced emesis: A summary
|
Pintens, H.
|
|
1990
|
17 |
2-3 |
p. 307-310
4 p.
|
artikel
|
| 13 |
Hexadecylphosphocholine: a new and selective antitumor drug
|
Eibl, H.
|
|
1990
|
17 |
2-3 |
p. 233-242
10 p.
|
artikel
|
| 14 |
Hexadecylphosphocholine in the topical treatment of skin metastases in breast cancer patients
|
Unger, Clemens
|
|
1990
|
17 |
2-3 |
p. 243-246
4 p.
|
artikel
|
| 15 |
High-dose versus intermediate-dose cytosine arabinoside in combination with mitoxantrone for the treatment of relapsed and refractory acute myeloid leukemia—preliminary clinical and pharmacological data of a randomized comparison
|
Hiddemann, Wolfgang
|
|
1990
|
17 |
2-3 |
p. 279-285
7 p.
|
artikel
|
| 16 |
Higher average received relative dose intensities of cyclophosphamide, methotrexate and 5-fluorouracil using a 24-hour method: Implications for improved cure rates in breast cancer
|
Price, Len A.
|
|
1990
|
17 |
2-3 |
p. 191-196
6 p.
|
artikel
|
| 17 |
High-intensity therapy versus low-intensity therapy in advanced breast cancer patients
|
Porzsolt, Franz
|
|
1990
|
17 |
2-3 |
p. 287-292
6 p.
|
artikel
|
| 18 |
Interstitial chemotherapy of experimental gliomas
|
Zeller, W.J.
|
|
1990
|
17 |
2-3 |
p. 183-189
7 p.
|
artikel
|
| 19 |
Invasion and metastasis control: implications for increased therapeutic index of antitumor drugs
|
Mareel, Marc
|
|
1990
|
17 |
2-3 |
p. 335-338
4 p.
|
artikel
|
| 20 |
In vitro and in vivo evaluation of US-NCI compounds in human tumor xenografts
|
Fiebig, Heinz-Herbert
|
|
1990
|
17 |
2-3 |
p. 109-117
9 p.
|
artikel
|
| 21 |
In vivo antitumour activity of ilmofosine
|
Herrmann, Dieter B.J.
|
|
1990
|
17 |
2-3 |
p. 247-252
6 p.
|
artikel
|
| 22 |
Modulation of antitumour drug resistance: experimental laboratory data and results of clinical evaluation
|
Hill, Bridget T.
|
|
1990
|
17 |
2-3 |
p. 197-202
6 p.
|
artikel
|
| 23 |
Modulation of cytotoxicity of cytostatic drugs by hemodialysis in vitro and in vivo
|
Sauer, Hansjörg
|
|
1990
|
17 |
2-3 |
p. 293-300
8 p.
|
artikel
|
| 24 |
Modulation of 5-fluorouracil efficacy
|
Herrmann, Richard
|
|
1990
|
17 |
2-3 |
p. 209-212
4 p.
|
artikel
|
| 25 |
New cytostatics—more activity and less toxicity
|
Berger, Martin R.
|
|
1990
|
17 |
2-3 |
p. 143-154
12 p.
|
artikel
|
| 26 |
New EORTC compounds
|
Lelieveld, P.
|
|
1990
|
17 |
2-3 |
p. 119-125
7 p.
|
artikel
|
| 27 |
New tumor-inhibiting metal complexes
|
Keppler, B.K.
|
|
1990
|
17 |
2-3 |
p. 261-277
17 p.
|
artikel
|
| 28 |
Novel anthracycline analogs
|
Grandi, Maria
|
|
1990
|
17 |
2-3 |
p. 133-138
6 p.
|
artikel
|
| 29 |
Oxazaphosphorine toxicity reduction by mesna
|
Hilgard, Peter
|
|
1990
|
17 |
2-3 |
p. 217-220
4 p.
|
artikel
|
| 30 |
Pentostatin (2′-deoxycoformycin) for the treatment of lymphoid neoplasms
|
Ho, Anthony D.
|
|
1990
|
17 |
2-3 |
p. 213-215
3 p.
|
artikel
|
| 31 |
Pharmacological interventions to reduce platinum-induced toxicity
|
Tognella, Sergio
|
|
1990
|
17 |
2-3 |
p. 139-142
4 p.
|
artikel
|
| 32 |
Pitfalls in the clinical application of monoclonal antibodies in malignant melanoma: modulation by and impaired accessibility of antigens to monoclonal antibodies
|
Tilgen, Wolfgang
|
|
1990
|
17 |
2-3 |
p. 357-371
15 p.
|
artikel
|
| 33 |
Platinum compounds with estrogen receptor affinity
|
Bednarski, Patrick J.
|
|
1990
|
17 |
2-3 |
p. 221-231
11 p.
|
artikel
|
| 34 |
Professor Dr med. Dietrich Schmähl
|
|
|
1990
|
17 |
2-3 |
p. 105-
1 p.
|
artikel
|
| 35 |
Regional chemotherapy: Different operative techniques and clinical results
|
Schlag, P.
|
|
1990
|
17 |
2-3 |
p. 177-182
6 p.
|
artikel
|
| 36 |
Second generation analogs of etoposide and mitomycin C
|
Doyle, Terrence W.
|
|
1990
|
17 |
2-3 |
p. 127-131
5 p.
|
artikel
|
| 37 |
The molecular basis of interstitial pulmonary fibrosis caused by antineoplastic agents
|
Lazo, John S.
|
|
1990
|
17 |
2-3 |
p. 165-167
3 p.
|
artikel
|
| 38 |
The use of haemoregulatory peptides (pEEDCK monomer and dimer) for reduction of cytostatic drug induced haemopoietic damage
|
Paukovits, W.R.
|
|
1990
|
17 |
2-3 |
p. 347-354
8 p.
|
artikel
|
| 39 |
Tumor heterogeneity and chemosensitivity to cyclophosphamide, vinblastine and hexadecylphosphocholine
|
Angres, Gabriele
|
|
1990
|
17 |
2-3 |
p. 339-345
7 p.
|
artikel
|
| 40 |
Two-phase radioimmunotherapy using bispecific monoclonal antibodies (bs MAbs)
|
Bosslet, K.
|
|
1990
|
17 |
2-3 |
p. 355-356
2 p.
|
artikel
|
Tijdschrift beschrijving